SUTRO BIOPHARMA, INC.
Develops engineered cancer drugs like ADCs using a cell-free protein synthesis platform.
STRO | US
Overview
Corporate Details
- ISIN(s):
- US8693671021
- LEI:
- Country:
- United States of America
- Address:
- 111 OYSTER POINT BLVD., 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.sutrobio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of cancer therapeutics. The company utilizes its proprietary and integrated cell-free protein synthesis platform, XpressCF®, to design and produce precisely engineered, next-generation treatments. Its primary focus is on advancing a pipeline of antibody-drug conjugates (ADCs) and other novel protein-based medicines to address unmet needs in oncology and provide improved outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SUTRO BIOPHARMA, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SUTRO BIOPHARMA, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SUTRO BIOPHARMA, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
